mesenchymal stem cell derived-exosome therapy

N/A

Report date: 2023/01/12 15:41:04

Base Information

Drug Namemesenchymal stem cell derived-exosome therapy
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co LtdYonsei University
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co LtdYonsei University
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A